Emergent biosolution stock.

Emergent Biosolutions stock declined 17% over the last ten trading days (2 weeks), compared to the broader market (S&P500) rise of 0.7%; A change of -17% or more over ten trading days is a 20% ...Emergent BioSolutions stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.Emergent BioSolutions reported $354.3M in Stock for its fiscal quarter ending in June of 2023. Data for Emergent BioSolutions | EBS - Stock including ...Nov. 4, 2021. WASHINGTON — The federal government has canceled its contract with a troubled Covid-19 vaccine manufacturer that ruined millions of doses and had to halt production for months ...

By Will Feuer . Shares of Emergent BioSolutions Inc. rose after the U.S. Food and Drug Administration said the company's overdose reversal medication Narcan could be sold over-the-counter for the first time since the opioid crisis began.

Track Emergent Biosolutions Inc (EBS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsShares of Emergent Biosolutions ( EBS -0.47%) have crashed 41.1% as of 11:44 a.m. EDT on Friday. The huge decline came after the company revealed on Thursday that a multimillion-dollar agreement ...

According to the issued ratings of 2 analysts in the last year, the consensus rating for Emergent BioSolutions stock is Reduce based on the current 1 sell rating and 1 hold rating for EBS. The average twelve-month price prediction for Emergent BioSolutions is $15.50 with a high price target of $22.00 and a low price target of $9.00.Emergent Biosolutions stock has rallied 111% since late March (vs. about 53% for the S&P 500) to its current level around $105. The stock fell to a low of $50 in late March when a rapid increase ...Emergent BioSolutions. Market Cap. $108M. Today's Change. (%) Current Price. $2.09. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ from ...Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently up 3.96% so far this month. During the month of May, Emergent Biosolutions Inc’s stock price has reached a high of $10.88 and a low of $8.20. Over the last year, Emergent Biosolutions Inc has hit prices as high as $40.45 and as low as $7.74.Shares of Emergent BioSolutions ( EBS -3.30%) were falling 4% as of 11:07 a.m. EDT on Thursday after sinking as much as 7.6% earlier in the day. The stock tumbled earlier this week after the ...

Shares of Emergent BioSolutions ( EBS -4.11%) were sinking 12.8% lower as of 10:53 a.m. ET on Friday. The decline came after J.P. Morgan analyst Jessica Fye downgraded the stock from a neutral ...

Jan 5, 2021 · Government contracts account for 61% of the company's sales for much of 2020. Since 2016, government agencies have stockpiled up to $6.4 billion worth of Emergent BioSolutions' products, including ...

During today's call, Emergent may make projections and other forward-looking statements related to their business, future events, the prospects, or future performance. Find the latest Emergent BioSolutions Inc. (EBS) stock quote, history, news and other vital information to help you with your stock trading and investing.Emergent BioSolutions reinstated with an Underweight at JPMorgan November 20, 2023TipRanks. Mixed Financial Outlook for Emergent Biosolutions: Strong Narcan Sales Offset by Lowered Guidance and ...Shares of Emergent BioSolutions (NYSE: EBS) were tumbling 10.6% lower as of 11:29 a.m. ET on Tuesday. The decline came after S&P Global's S&P Dow Jones Indices announced that Advance Auto Parts will replace Emergent BioSolutions in the S&P SmallCap 600 index. S&P Dow Jones Indices said that … See moreEmergent Biosolutions is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Exact Sciences (EXAS), a stock from the same industry, has gained 6.4%.Emergent BioSolutions Inc. (NYSE:NYSE:EBS) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ETCompany ParticipantsBob Burrows - VP, IRBob Kramer -...Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV.10 stocks we like better than Emergent BioSolutions When o ur award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley ...

Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody Subscribe to newsletters Subscribe: $29.99/yearN/A. N/A. See Emergent BioSolutions Inc. (EBS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Emergent Biosolutions Inc (EBS) stock is higher by 10.46% while the S&P 500 is down -0.6% as of 1:08 PM on Monday, Dec 4. EBS has gained $0.25 from the …30 thg 4, 2021 ... Biotech firm Emergent BioSolutions is under scrutiny after quality control issues forced millions of potential COVID-19 vaccines to be ...10 stocks we like better than Emergent BioSolutions When o ur analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock ...Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, ... Kramer's previous significant sale of company stock under a SEC Rule 10b-5 plan was in April 2016, and several other Emergent executives also sold stock at that time.Apr 30, 2021 · For Emergent BioSolutions, Feb. 8 was a day to revel in their success -- at least as far as the public was concerned. ... accused Emergent executives of inflating the company's stock price by ...

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown.

The FDA approved Emergent BioSolutions Inc's (NYSE:EBS) anthrax vaccine for adults aged 18 through 65.. The vaccine Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, is ...Benchmark upgraded Emergent BioSolutions Inc (NYSE:EBS) from Hold To Buy with a price target of $22 on the positive FDA and Narcan market news.; Related: FDA Approves First OTC Naloxone Nasal ...See the latest Emergent BioSolutions Inc stock price (EBS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.Emergent Biosolutions is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Axsome Therapeutics (AXSM), a stock from the same industry, has gained 16.4%.Emergent has been delivering CYFENDUS™ vaccine to the U.S. Department of Health and Human Services since 2019, under pre-Emergency Use Authorization status, and will continue to work with the U.S. government to transition to post-approval procurement; GAITHERSBURG, Md., July 20, 2023 (GLOBE NEWSWIRE) -- Emergent …Revenue Metrics. Total revenues for 2022 are expected to be in the range of $1,100 million to $1,120 million, a decrease at the midpoint of $683 million or 38% as compared to 2021. Profitability ...The closing price is not necessarily indicative of future price performance. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website …

See Emergent BioSolutions Inc. (EBS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

According to the issued ratings of 2 analysts in the last year, the consensus rating for Emergent BioSolutions stock is Reduce based on the current 1 sell rating and 1 hold rating for EBS. The average twelve-month price prediction for Emergent BioSolutions is $15.50 with a high price target of $22.00 and a low price target of $9.00.

Emergent BioSolutions ruined millions of doses of Covid-19 vaccines. Now its $600 million deal is canceled. Share full article. One of Emergent BioSolutions’ plants in Baltimore last April.Aug 2, 2022 · What happened. Shares of Emergent BioSolutions ( EBS -1.91%) are sinking today, down 11.8% as of 11:27 a.m. ET. The decline came after the company announced its second-quarter financial results ... Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing. GAITHERSBURG, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today confirmed that on November 16, 2023, the New York Stock Exchange (NYSE) sent a notice that the company is not in compliance with Section …Contract drugmaker Emergent BioSolutions Inc said on Thursday it is aiming to price the over-the-counter (OTC) version of its opioid overdose reversal drug Narcan at around $50 per carton.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Emergent BioSolutions has seen a significant revenue decline and stock value drop within the past year. The FDA has approved Emergent's over-the-counter Narcan, a drug to treat opioid overdoses.See Emergent BioSolutions Inc. (EBS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Dec 1, 2023 · Emergent BioSolutions stock has received a consensus rating of buy. The average rating score is and is based on 5 buy ratings, 3 hold ratings, and 1 sell ratings. What was the 52-week low for ...

Emergent BioSolutions stock has received a consensus rating of buy. The average rating score is and is based on 5 buy ratings, 3 hold ratings, and 1 sell ratings.Emergent Biosolutions shares plunged by more than 37% on Friday after the company disclosed it "mutually agreed" with the federal government to cancel a $628 million contract after botching Covid ...Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 21.73% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $9.40. Over the last year, Emergent Biosolutions Inc has hit prices as high as $45.14 and as …Mar 29, 2023 · Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 24.48% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $7.74. Over the last year, Emergent Biosolutions Inc has hit prices as high as $44.39 and as low as $7.74. Instagram:https://instagram. gold block pricebest site to day tradepurchase wwe stockelf makeup stock 25 thg 4, 2021 ... The chief of Emergent BioSolutions made sales of stock options weeks before the company's share price tumbled.GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that it has entered into an agreement to sell its travel health business to Bavarian Nordic ... forex brokers in indiabest whole life insurance cash value Emergent Biosolutions Inc. analyst ratings, historical stock prices, ... Actuals & Estimates Emergent Biosolutions Inc. Quarterly; Annual; Actual Analyst Range Consensus. 2.00 …EBS earnings call for the period ending September 30, 2023. Image source: The Motley Fool. Emergent BioSolutions ( EBS 11.68%) Q3 2023 Earnings Call. Nov 08, 2023, 5:00 p.m. ET. vanguard high yield fund Emergent Biosolutions Inc. analyst ratings, historical stock prices, earnings estimates & actuals. EBS updated stock price target summary.Emergent BioSolutions Contacts: Media: Matt Hartwig Senior Director, Media Relations 240-760-0551 [email protected] Investors: Robert G. Burrows Vice President, Investor Relations 240-631-3280 [email protected]